NBQX or topiramate treatment after perinatal hypoxia-induced seizures prevents later increases in seizure-induced neuronal injury

Epilepsia

Volumn 45, Issue 6, 2004, Pages 569-575

  Koh, Sookyong ^a,c   Tibayan, Felicia D ^a   Simpson, Joelle N ^a   Jensen, Frances E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

AMPA; Cell death; Epilepsy; Kainate; Neonatal seizures; Neuroprotection

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; AMPA RECEPTOR; KAINIC ACID; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG EFFICACY; HIPPOCAMPUS; HYPOXIA; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SEIZURE; TREATMENT OUTCOME;

ANIMALS; ANTICONVULSANTS; BRAIN; CELL DEATH; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; FRUCTOSE; HIPPOCAMPUS; HYPOXIA, BRAIN; IN SITU NICK-END LABELING; KAINIC ACID; MALE; NEURONS; NEUROPROTECTIVE AGENTS; QUINOXALINES; RATS; RATS, LONG-EVANS; RECEPTORS, AMPA; SEIZURES;

EID: 3042692042     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2004.69103.x     Document Type: Article

References (52)

1. Volpe JJ. Neurology of the newborn. 4th ed. Philadelphia: WB Saunders, 2000.
2. Bergamasco B, Benna P, Ferrero P, et al. Neonatal hypoxia and epileptic risk: a clinical prospective study. Epilepsia 1984;25:131-6.
3. Legido A, Clancy RR, Berman PH. Neurologic outcome after electroencephalographically proven neonatal seizures. Pediatrics 1991;88:583-96.
4. Clancy RR, Legido A. Postnatal epilepsy after EEG-confirmed neonatal seizures. Epilepsia 1991;32:69-76.
5. Nelson KB, Ellenberg JH. Predictors of epilepsy in children who have experienced febrile seizures. N Engl J Med 1976;295:1029-33.
6. Annegers JF, Hauser WA, Shirts SB, et al. Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med 1987;316:493-8.
7. Berg AT, Shinnar S. Do seizures beget seizures? An assessment of the clinical evidence in humans. J Clin Neurophysiol 1997;14:102-10.
8. Falconer M, Serafetinides E, Corsellis J. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 1964;10:233-48.
9. Harvey AS, Grattan-Smith JD, Desmond PM, et al. Febrile seizures and hippocampal sclerosis: frequent and related findings in intractable temporal lobe epilepsy of childhood. Pediatr Neurol 1995;12:201-6.
10. Cendes F, Andermann F, Dubeau F, et al. Early childhood prolonged febrile convulsions, atrophy and sclerosis of mesial structures, and temporal lobe epilepsy: an MRI volumetric study. Neurology 1993;43:1083-7.
11. Wasterlain CG. Effects of neonatal status epilepticus on rat brain development. Neurology 1976;26:975-86.
12. Moshe SL, Albala BJ. Maturational changes in postictal refractoriness and seizure susceptibility in developing rats. Ann Neurol 1983;13:552-57.
13. Jensen FE, Holmes GL, Lombroso CT, et al. Age-dependent changes in long-term seizure susceptibility and behavior after hypoxia in rats. Epilepsia 1992;33:971-80.
14. Holmes GL, Gairsa JL, Chevassus-au-Louis N, et al. Consequences of neonatal seizures in the rat: morphological and behavioral effects. Ann Neurol 1998;44:845-57.
15. Dube C, Chen K, Eghbal-Ahmadi M, et al. Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term. Ann Neurol 2000;47:336-44.
16. Jensen FE, Wang C, Stafstrom CE, et al. Acute and chronic increases in excitability in rat hippocampal slices after perinatal hypoxia In vivo. J Neurophysiol 1998;79:73-81.
17. Chen K, Baram TZ, Soltesz I. Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits. Nat Med 1999;5:888-94.
18. Villeneuve N, Ben-Ari Y, Holmes GL, et al. Neonatal seizures induced persistent changes in intrinsic properties of CA1 rat hippocampal cells. Ann Neurol 2000;47:729-38.
19. Albala BJ, Moshe SL, Okada R. Kainic-acid-induced seizures: a developmental study. Brain Res 1984;315:139-48.
20. Toth Z, Yan XX, Haftoglou S, et al. Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J Neurosci 1998;18:4285-94.
21. Sankar R, Shin DH, Liu H, et al. Patterns of status epilepticus-induced neuronal injury during development and long-term consequences. J Neurosci 1998;18:8382-93.
22. Koh S, Storey TW, Santos TC. et al. Early-life seizures in rats increase susceptibility to seizure-induced brain injury in adulthood. Neurology 1999;53:915-211.
23. Schmid R, Tandon P, Stafstrom CE, et al. Effects of neonatal seizures on subsequent seizure-induced brain injury. Neurology 1999;53:1754-61.
24. Koh S, Jensen FE. Topiramate blocks perinatal hypoxia-induced seizures in rat pups. Ann Neurol 2001;50:366-72.
25. Jensen FE, Applegate CD, Holtzman D, et al. Epileptogenic effect of hypoxia in the immature rodent brain. Ann Neurol 1991;29:629-37.
26. Swann JW, Gomez-Di Cesare CM. Developmental plasticity and hippocampal epileptogenesis. Hippocampus 1994;4:266-9.
27. Pellegrini-Giampietro DE, Bennett MV, Zukin RS. Differential expression of three glutamate receptor genes in developing rat brain: an in situ hybridization study. Proc Natl Acad Sci USA 1991;88:4157-61.
28. Insel TR, Miller LP, Gelhard RE. The ontogeny of excitatory amino acid receptors in rat forebrain. I. N-methyl-D-aspartate and quisqualate receptors. Neuroscience 1990;35:31-43.
29. Muller D, Lynch G. Long-term potentiation differentially affects two components of synaptic responses in hippocampus. Proc Natl Acad Sci USA 1988;85:9346-50.
30. Davies SN, Lester RA, Reymann KG, et al. Temporally distinct pre- and post-synaptic mechanisms maintain long-term potentiation. Nature 1989;338:500-3.
31. Madison DV, Malenka RC, Nicoll RA. Mechanisms underlying long-term potentiation of synaptic transmission. Annu Rev Neurosci 1991;14:379-97.
32. Sanchez RM, Koh S, Rio C, et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 2001;21:8154-63.
33. Kumar SS, Bacci A, Kharazia V, et al. A developmental switch of AMPA receptor subunits in neocortical pyramidal neurons. J Neurosci 2002;22:3005-15.
34. Jensen FE, Blume H, Alvarado S, et al. NBQX blocks acute and late epileptogenic effects of perinatal hypoxia. Epilepsia 1995;36:966-72.
35. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 2nd ed. Sydney: Academic Press. 1986.
36. Wijsman JH, Jonker RR, Keijzer R, et al. A new method to detect apoptosis in paraffin sections: in situ end-labeling of fragmented DNA. J Histochem Cytochem 1993;41:7-12.
37. Andine P, Orwar O, Jacobson I, et al. Changes in extracellular amino acids and spontaneous neuronal activity during ischemia and extended reflow in the CA1 of the rat hippocampus. J Neurochem 1991;57:222-9.
38. Li H, Buchan AM. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J Cereb Blood Flow Metab. 1993;13:933-9.
39. Buchan A, Li H, Pulsinelli WA. The N-methyl-D-aspartate antagonist. MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J Neurosci 1991;11:1049-56.
40. Nellgard B, Wieloch T. Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp Brain Res 1992;92:259-66.
41. Ying HS, Weishaupt JH, Grabb M, et al. Sublethal oxygen-glucose deprivation alters hippocampal neuronal AMPA receptor expression and vulnerability to kainate-induced death. J Neurosci 1997;17:9536-44.
42. Calderone A, Jover T, Noh KM, et al. Ischemic insults derepress the gene silencer REST in neurons destined to die. J Neurosci 2003;23:2112-21.
43. Jiang M, Lee CL, Smith KL, et al. Spine loss and other persistent alterations of hippocampal pyramidal cell dendrites in a model of early-onset epilepsy. J Neurosci 1998;18:8356-68.
44. Nitecka L, Tremblay E, Charton G, et al. Maturation of kainic acid seizure-brain damage syndrome in the rat, II: histopathological sequelae. Neuroscience 1984;13:1073-94.
45. Tandon P, Yang Y, Das K, et al. Neuroprotective effects of brain-derived neurotrophic factor in seizures during development. Neuroscience 1999;91:293-303.
46. Marks JD, Friedman JE, Haddad GG. Vulnerability of CA1 neurons to glutamate is developmentally regulated. Brain Res Dev Brain Res 1996;97:194-206.
47. Nabetani M, Okada Y, Takata T, et al. Neural activity and intracellular Ca2+ mobilization in the CA1 area of hippocampal slices from immature and mature rats during ischemia or glucose deprivation. Brain Res 1997;769:158-62.
48. Vannucci RC, Brucklacher RM, Vannucci SJ. Intracellular calcium accumulation during the evolution of hypoxic-ischemic brain damage in the immature rat. Brain Res Dev Brain Res 2001;126:117-20.
49. Stafstrom CE, Thompson JL, Holmes GL. Kainic acid seizures in the developing brain: status epilepticus and spontaneous recurrent seizures. Brain Res Dev Brain Res. 1992;65:227-36.
50. French JA, Williamson PD, Thadani VM, et al. Characteristics of medial temporal lobe epilepsy, I: results of history and physical examination. Ann Neurol 1993;34:774-80.
51. Wieser HG, Engel JJ, Williams PD, et al. Surgically remediable temporal lobe syndromes. 2nd ed. New York: Raven Press, 1993:49-63.
52. Sillanpaa M, Jalava M, Kaleva O, et al. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338:1715-22.